Drug Resistance, Multiple, Viral
"Drug Resistance, Multiple, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation.
| Descriptor ID |
D024921
|
| MeSH Number(s) |
G06.225.420.500 G06.920.225.500 G07.690.773.984.269.420.500 G07.690.773.984.300.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple, Viral".
- Biological Sciences [G]
- Microbiological Phenomena [G06]
- Drug Resistance, Microbial [G06.225]
- Drug Resistance, Viral [G06.225.420]
- Drug Resistance, Multiple, Viral [G06.225.420.500]
- Virus Physiological Phenomena [G06.920]
- Drug Resistance, Viral [G06.920.225]
- Drug Resistance, Multiple, Viral [G06.920.225.500]
- Physiological Phenomena [G07]
- Pharmacological and Toxicological Phenomena [G07.690]
- Pharmacological Phenomena [G07.690.773]
- Drug Resistance [G07.690.773.984]
- Drug Resistance, Microbial [G07.690.773.984.269]
- Drug Resistance, Viral [G07.690.773.984.269.420]
- Drug Resistance, Multiple, Viral [G07.690.773.984.269.420.500]
- Drug Resistance, Multiple [G07.690.773.984.300]
- Drug Resistance, Multiple, Viral [G07.690.773.984.300.750]
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple, Viral".
This graph shows the total number of publications written about "Drug Resistance, Multiple, Viral" by people in this website by year, and whether "Drug Resistance, Multiple, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Multiple, Viral" by people in Profiles.
-
Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, P?rez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy. 2024 05; 44(5):354-359.
-
Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, P?rez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy. 2024 05; 44(5):360-382.
-
Alhefzi M, Aycart MA, Bueno EM, Kueckelhaus M, Fischer S, Snook RJ, Sharfuddin AA, Hadad I, Malla P, Amato AA, Pomahac B, Marty FM. Guillain-Barr? syndrome associated with resistant cytomegalovirus infection after face transplantation. Transpl Infect Dis. 2016 Apr; 18(2):288-92.
-
Walmsley SL, Squires K, Weiss L, Easterbrook P, Orani A, Kraft M, Scherer J. Multidrug-experienced HIV-1-infected women demonstrated similar virological and immunological responses to tipranavir/ritonavir compared with men. AIDS. 2009 Jan 28; 23(3):429-31.
-
Qi X, Xiong S, Yang H, Miller M, Delaney WE. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther. 2007; 12(3):355-62.
-
Romano L, Venturi G, Bloor S, Harrigan R, Larder BA, Major JC, Zazzi M. Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118. J Infect Dis. 2002 Apr 01; 185(7):898-904.